Inhibition of sequestration of human B2 bradykinin receptor by phenylarsine oxide or sucrose allows determination of a receptor affinity shift and ligand dissociation in intact cells.
Depending on their interaction with intracellular proteins, G protein-coupled receptors (GPCR) often display different affinities for agonists at 37 degrees C. Determining the affinity at that temperature is often difficult in intact cells as most GPCRs are internalized after activation. When sequestration of the B2 bradykinin receptor (B2R) was inhibited by either 0.5 M sucrose or phenylarsine oxide (PAO), a shift in the affinity was detected when the incubation temperature was raised from 4 degrees C to 37 degrees C or lowered from 37 degrees C to 4 degrees C. In contrast, binding of the antagonist [3H]NPC 17731 was temperature-independent. B2R mutants displayed different affinity shifts allowing conclusions on the role of the involved amino acids. By inhibiting receptor sequestration it was possible to determine also dissociation of [3H]BK and of [3H]NPC 17731 from intact cells at 37 degrees C. Surprisingly, both dissociation rates were markedly enhanced by the addition of unlabeled ligand, most likely via prevention of reassociation of dissociated [3H]ligand. This suggests that dissociated [3H]ligand cannot move freely away from the receptor. In summary, our data demonstrate that inhibition of receptor internalization either by PAO or sucrose provides an excellent method to study receptor function and the effects of mutations in intact cells.
Faussner
Alexander
A
Ludwig-Maximilians-Universität München, Abteilung für Klinische Chemie und Klinische Biochemie, Nussbaumstrasse 20, D-80336 München, Germany. alexander.faussner@med.uni-muenchen.de
Schuessler
Steffen
S
Seidl
Cornelia
C
Jochum
Marianne
M
D001152:Arsenicals / Q000494:pharmacology*; D001920:Bradykinin / Q000378:metabolism / Q000494:pharmacology; D065094:Bradykinin B2 Receptor Antagonists; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008024:Ligands; D011485:Protein Binding / Q000187:drug effects / Q000502:physiology; D043782:Receptor, Bradykinin B2 / Q000378:metabolism*; D013395:Sucrose / Q000494:pharmacology*
D001152:Arsenicals; D065094:Bradykinin B2 Receptor Antagonists; D008024:Ligands; D043782:Receptor, Bradykinin B2; C029341:oxophenylarsine; D013395:Sucrose; D001920:Bradykinin